AIM VACCINE (06660.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Aug27

AIM VACCINE released FY2025 Q1 earnings on August 27 (BJT), actual revenue HKD 275.59 M, actual EPS HKD -0.0589

15:00

AIM VACCINE released FY2025 Q2 earnings on August 27 During-Market (BJT), actual revenue HKD 281.65 M, actual EPS HKD -0.0601

08:00

AIM VACCINE released FY2025 Semi-Annual Earnings on August 27 During-Market (BJT), actual revenue HKD 557.24 M, actual EPS HKD -0.1191

08:00

Aug19

AIM VACCINE to Release FY2025 Semi-Annual Earnings on August 27, 2025 (BJT)

01:42

Jul17

Emei Vaccine's mRNA Shingles Vaccine Approved in China and US

07:17

Jul11

AIM Vaccine's ESG Rating Dropped to BB

01:13

Schedules & Filings

Schedules

Filings

Aug27

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 281.65 M, Net Income -71.75 M, EPS -0.0601

Mar28

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 397.8 M, Net Income -73.4 M, EPS -0.0638

Aug29

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 288.61 M, Net Income -74.82 M, EPS -0.0617

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More